About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 1NCT03224260

To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants

Access the safety, tolerability, and pharmacokinetics of BMS-986177 in healthy Japanese participants after multiple doses are administered.

Lead sponsor: Bristol-Myers Squibb•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Bristol-Myers Squibb

Age

18 - 55 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Participants must be first-generation Japanese (born in Japan and not living outside of Japan for \> 10 years; both parents must be ethnically Japanese)
•Body Mass Index 18.0 to 25.0 kg/m2, inclusive
•Women must not be of nonchildbearing potential (cannot become pregnant)

Exclusion Criteria

•Any significant acute or chronic medical illness
•History of allergy to BMS-986177 or other factor Xia inhibitors and/or formulation excipients or history of any significant drug allergy (such as anaphylaxis or hepatotoxicity)
•History or evidence of abnormal bleeding or coagulation disorder

Related studies

RevCore for In Stent Thrombosis

NCT06394739 · In-stent Thrombosis

ATHNdataset Registry

NCT06820515 · Hemophilia, Thrombosis, and more

RECRUITINGPhase 2

Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

NCT05969496 · Renal Cancer, Kidney Cancer, and more

RECRUITINGPhase 3

Efficacy and Safety of Tenecteplase Bridging Mechanical Thrombectomy for Acute Large Vessel Occlusion Stroke

NCT06658197 · Stroke, Ischemic, Stroke, Acute, and more

RECRUITINGPhase 3

REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis

NCT07410117 · Cancer-Associated Thrombosis (CAT)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 1, 2018Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment33

Start dateJun 2017

Last updatedJun 1, 2018

Condition

Locations shown

West Coast Clinical Trials

Anaheim, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 1, 2018Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions